Sana Biotechnology, Inc.’s SANA share price has surged by 7.80%, which has investors questioning if this is right time to sell.

CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making ...

Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.

In a breakthrough with promising real-world applications, a team of Rutgers biophysicists, bioengineers, and plant biologists ...

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...

Moleculin Biotech Background Information (This description ... for the topical treatment of cutaneous T-cell lymphoma. Moleculin is also engaged in preclinical development of additional drug ...

A far-reaching study has cast doubt on statistical methods used to identify long-distance signaling networks in plants. The ...

Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are ...